Roivant sciences executive sells common shares worth $4.97 million By Investing.com

Roivant sciences executive sells common shares worth 497 million By

Roivant Sciences Ltd. (NASDAQ:), a biopharmaceutical company with a market capitalization of $8.4 billion…

www.investing.com

More posts

NextGen Digital Provides Business Progress Updates and Announces Strategic Expansion By Investing.com

December 21, 2024
ROSEN, A LEADING LAW FIRM, Encourages Joint Stock Company Kaspi.kz Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm

December 21, 2024
Roivant sciences executive sells common shares worth $4.97 million By Investing.com

December 21, 2024
Biden administration withdraws proposed rule limiting transgender bans in sports By Reuters

December 21, 2024